Stocktoria
IDEAYA Biosciences, Inc. IDYA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-23
Chart by TradingView
3/9
Piotroski F — financial health
12.9
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $218.7M | $7.0M | $23.4M | $50.9M | $27.9M |
| Operating income | -$159.3M | -$327.0M | -$134.4M | -$62.5M | -$50.3M |
| Net income | -$113.7M | -$274.5M | -$113.0M | -$58.7M | -$49.8M |
| Operating cash flow | -$71.1M | -$247.6M | -$115.2M | -$87.2M | -$55.8M |
| Free cash flow | -$73.5M | -$251.4M | -$117.6M | -$90.6M | -$58.4M |
| Total assets | $1.1B | $1.1B | $649.3M | $388.0M | $381.3M |
| Total liabilities | $86.4M | $64.9M | $28.2M | $38.5M | $79.8M |
| Shareholders' equity | $1.0B | $1.1B | $621.1M | $349.5M | $301.5M |
| Ratios | |||||
| Operating margin | -72.8% | -4671.1% | -574.9% | -122.7% | -179.9% |
| Net margin | -52.0% | -3921.1% | -483.0% | -115.2% | -178.1% |
| FCF margin | -33.6% | -3592.0% | -502.9% | -177.9% | -209.1% |
| Return on assets | -10.2% | -24.4% | -17.4% | -15.1% | -13.0% |
| Return on equity | -11.1% | -25.9% | -18.2% | -16.8% | -16.5% |
| Current ratio | 11.34 | 14.97 | 19.65 | 11.68 | 5.56 |
| Revenue growth | 3024.4% | -70.1% | -54.1% | 82.3% | 43.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 327,901 | $10.9M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 12.9 (safe)
- Working capital / assets 0.548
- Retained earnings / assets -0.664
- EBIT / assets -0.144
- Equity / liabilities 11.841
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001676725 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.